Clinical diagnostics company Envision Sciences has appointed Scott Richards as its new chief executive officer. Envision is developing and commercialising a pipeline of novel biomarker-based cancer diagnostic and prognostic tests in tissue and blood. Mr Richards has over 35 years of experience in the global pharmaceutical industry, leading significant commercial-stage enterprises in Australia, Europe and […]
